Jean-Christophe Leroux
Leroux, Jean-Christophe 1969-
VIAF ID: 1302145857146722922967 (Personal)
Permalink: http://viaf.org/viaf/1302145857146722922967
Preferred Forms
- 100 0 _ ‡a Jean-Christophe Leroux
- 100 1 _ ‡a Leroux, Jean-Christophe ‡d 1969-
4xx's: Alternate Name Forms (3)
5xx's: Related Names (4)
- 510 2 _ ‡a Eidgenössische Technische Hochschule Zürich ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Montréal ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _ ‡a Université de Genève ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Université de Montréal ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
3D printing of a wearable personalized oral delivery device: A first-in-human study. | |
Ammonia uptake by transmembrane pH gradient poly(isoprene)-block-poly(ethylene glycol) polymersomes | |
Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes | |
Development of a Modular Ratiometric Fluorescent Probe for the Detection of Extracellular Superoxide | |
Editorial: Drug Delivery: Too Much Complexity, Not Enough Reproducibility? | |
Editorial: Drug Delivery: zu kompliziert und nicht reproduzierbar genug? | |
Engineered Polymersomes for the Treatment of Fish Odor Syndrome: A First Randomized Double Blind Olfactory Study | |
Engineering Lipid Spherulites for the Sustained Release of Highly Dosed Small Hydrophilic Compounds | |
Exosomes for Wound Healing: Purification Optimization and Identification of Bioactive Components | |
The Illusion and Disillusion of Peer Review | |
Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers | |
Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies | |
Investigating the Mechanism of Cyclodextrins in the Treatment of Niemann-Pick Disease Type C Using Crosslinked 2-Hydroxypropyl-β-cyclodextrin | |
Investigational Pharmacological Treatments for Vascular Calcification | |
Is 3D Printing of Pharmaceuticals a Disruptor or Enabler? | |
Liposome-supported peritoneal dialysis in the treatment of severe hyperammonemia: An investigation on potential interactions | |
Microinjection for the ex Vivo Modification of Cells with Artificial Organelles | |
A microparticulate based formulation to protect therapeutic enzymes from proteolytic digestion: phenylalanine ammonia lyase as case study | |
Nanopharmaceuticals: A focus on their clinical translatability | |
Peritoneal dialysis beyond kidney failure? | |
Poly(ethylene glycol)-alendronate coated nanoparticles for magnetic resonance imaging of lymph nodes | |
Serum-stable, long-circulating, pH-sensitive PEGylated liposomes. | |
Small-Molecule Allosteric Triggers of Clostridium difficile Toxin B Auto-proteolysis as a Therapeutic Strategy | |
The TFAMoplex-Conversion of the Mitochondrial Transcription Factor A into a DNA Transfection Agent | |
Transmembrane pH-Gradient Liposomes To Treat Cardiovascular Drug Intoxication | |
Twenty-five years of polymersomes: lost in translation? |